Nika Pharmaceuticals Inc.
OTC: NIKA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dimitar Slavchev Savov
- Headquarters
- Henderson, United States
- IPO year
- 2024
- Market cap
- $211.8M
- Website
- https://www.nikapharmaceuticals.com
Loading NIKA…
Loading profile data…Frequently asked questions about NIKA
What does Nika Pharmaceuticals Inc. (NIKA) do?
Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious diseases including HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, and diabetes. The company's product l...
Where does NIKA trade?
Nika Pharmaceuticals Inc. (NIKA) trades on the Other OTC.
What sector is NIKA in?
Nika Pharmaceuticals Inc. (NIKA) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Nika Pharmaceuticals Inc.?
Dimitar Slavchev Savov is the chief executive officer of Nika Pharmaceuticals Inc. (NIKA).
Where is Nika Pharmaceuticals Inc. headquartered?
Nika Pharmaceuticals Inc. is headquartered in United States.
Does NIKA pay a dividend?
Nika Pharmaceuticals Inc. (NIKA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NIKA go public?
Nika Pharmaceuticals Inc. (NIKA) completed its initial public offering in 2024.